Healthy lifestyle and life expectancy at age 30 years in the Chinese population: an observational study. Lancet Public Health. 2022;7(12):e994–1004. Article Google Scholar Lackner C, Tiniakos D. Fibrosis and alcohol-related liver disease. J Hepatol. 2019;70(2):294–304. Article Google ...
Palliative care is by definition meant for malignant states with known short life expectancy. It is commendable in AdHF patients to prefer the term of “end-of-life” care. As opposed to the management of cancer patients, the length of this stage is hard to predict in the heart failure ...
View PDF Download full issue Search ScienceDirect Journal of the National Cancer Center Volume 4, Issue 2, June 2024, Pages 107-127Practice GuidelinesGuidelines for diagnosis and treatment of advanced breast cancer in China (2022 edition)☆ Author links open overlay panel...
Heyse-Moore LHJohnson-Bell VE Can doctors accurately predict the life expectancy of patients with terminal cancer? Palliat Med. 1987;1165- 166Google ScholarCrossref 27. Forster LELynn J Predicting life span for applicants to inpatient hospice. Arch Intern Med. ...
32 For patients with advanced illness, underlying organ failure (kidney, liver, and heart) potentially offsets the beneficial effects of statins even when reductions in low-density lipoprotein levels are achieved.28 Indeed, the finding of a decreased survival benefit in sicker patients and a ...
In industrialized countries, the incidence of HF is increasing as the average life expectancy increases, and the HF pandemic era is imminent4. Furthermore, there are some juvenile cases of medically intractable HF, which is another important issue in medical care for HF5. There is an unmet ...
Other inclusion criteria included having a minimum of one measurable lesion, in terms of the Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1, Eastern Cooperative Oncology Group performance status (ECOG PS) score of 0–1, a life expectancy ≥6 months, and sufficient bone marrow ...
patients must have measurable disease as determined by RECIST version 1.1 and documented by computed tomography and/or magnetic resonance imaging, an ECOG performance status of 0 or 1, a life expectancy of 12 weeks of greater, and resolution of all chemotherapy or radiation-related toxicit...
Skip to main contentSkip to article Journals & Books Help Search
Hepatitis B or C infection with detectable viral load and liver fibrosis • Chest wall or spinal deformity expected to cause restriction after transplant • Extracorporeal life support • Retransplantation for restrictive CLAD, antibody-mediated rejection, or within 1 y following initial lung transp...